Mankind Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
1,990.00
-11.15 (-0.56%)
BSENSE

Apr 02

BSE+NSE Vol: 7.34 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryMankind Pharma VS Pharmaceuticals & Biotechnology
 
1D
-0.56%
0.25%
1W
-1.5%
-2.6%
1M
-11.36%
-8.62%
YTD
-9.4%
-13.96%
1Y
-17.8%
-4.3%
3Y
%
24.29%
5Y
%
46.55%
10Y
%
190.15%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.05%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.65%
0%
-9.65%
6 Months
-18.4%
0%
-18.4%
1 Year
-17.8%
0.04%
-17.76%
2 Years
-16.97%
0.04%
-16.93%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 1 per share ex-dividend date: Aug-08-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available